Literature DB >> 26239725

microRNA-22 downregulation of galectin-9 influences lymphocyte apoptosis and tumor cell proliferation in liver cancer.

Qianqian Yang1, Weichao Jiang1, Chunbo Zhuang1, Zhi Geng1, Chen Hou1, Da Huang1, Lihua Hu1, Xiaobei Wang1.   

Abstract

Galectin-9 (Gal-9) plays an important role in both the immune response and tumor progression, while microRNAs act as tumor regulators to mediate tumorigenesis. However, the underlying molecular mechanisms remain unknown. In the present study, we investigated the relationship between Gal-9 and microRNA-mediated regulation in liver cancer. We examined Gal-9 expression using qRT-PCR and western blot analysis and found that it was markedly upregulated in human liver cancer cells compared with the level in normal hepatocytes. We co-cultured peripheral blood mononuclear cells (PBMCs) and tumor cells and observed that Gal-9 induced lymphocyte apoptosis and tumor cell immune escape using flow cytometric analysis and WST-1 assay. We found that miR-22 was downregulated in liver cancer tissues and cell lines and confirmed that miR-22 directly targeted the Gal-9 3'UTR and negatively regulated Gal-9 expression by luciferase reporter assay and transfection of microRNA mimics. We also observed that the Gal-9/miR-22 axis may influence lymphocyte apoptosis and tumor cell proliferation. These studies contribute to a further understanding of the microRNA‑mediated regulation of the Gal-9 pathway and elucidate novel therapeutic targets for liver cancer.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26239725     DOI: 10.3892/or.2015.4167

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  19 in total

Review 1.  Galectin-9: Diverse roles in hepatic immune homeostasis and inflammation.

Authors:  Lucy Golden-Mason; Hugo R Rosen
Journal:  Hepatology       Date:  2017-05-27       Impact factor: 17.425

Review 2.  Galectin-9: From cell biology to complex disease dynamics.

Authors:  Sebastian John; Rashmi Mishra
Journal:  J Biosci       Date:  2016-09       Impact factor: 1.826

3.  MicroRNA-22 controls interferon alpha production and erythroid maturation in response to infectious stress in mice.

Authors:  Claudine S Kadmon; Cameron T Landers; Haiyan S Li; Stephanie S Watowich; Antony Rodriguez; Katherine Y King
Journal:  Exp Hematol       Date:  2017-09-11       Impact factor: 3.084

4.  miR-455-5p functions as a potential oncogene by targeting galectin-9 in colon cancer.

Authors:  Qianqian Yang; Chen Hou; Da Huang; Chunbo Zhuang; Weichao Jiang; Zhi Geng; Xiaobei Wang; Lihua Hu
Journal:  Oncol Lett       Date:  2017-01-17       Impact factor: 2.967

Review 5.  Critical appraisal of epigenetic regulation of galectins in cancer.

Authors:  Ashita Gadwal; Anupama Modi; Manoj Khokhar; Jeewan Ram Vishnoi; Ramkaran Choudhary; Poonam Elhence; Mithu Banerjee; Purvi Purohit
Journal:  Int J Clin Oncol       Date:  2021-10-15       Impact factor: 3.402

Review 6.  The emerging role of galectins in high-fatality cancers.

Authors:  Cherylane Dubé-Delarosbil; Yves St-Pierre
Journal:  Cell Mol Life Sci       Date:  2017-11-08       Impact factor: 9.261

7.  RARβ acts as both an upstream regulator and downstream effector of miR-22, which epigenetically regulates NUR77 to induce apoptosis of colon cancer cells.

Authors:  Ying Hu; Samuel W French; Thinh Chau; Hui-Xin Liu; Lili Sheng; Fang Wei; Jesse Stondell; Juan C Garcia; Yanlei Du; Christopher L Bowlus; Yu-Jui Yvonne Wan
Journal:  FASEB J       Date:  2018-09-25       Impact factor: 5.191

8.  miR-22 inhibits the proliferation, motility, and invasion of human glioblastoma cells by directly targeting SIRT1.

Authors:  Hanchun Chen; Qiong Lu; Xifeng Fei; Likui Shen; Dongyi Jiang; Dongwei Dai
Journal:  Tumour Biol       Date:  2015-12-10

9.  LncRNA NBR2 aggravates hepatoblastoma cell malignancy and promotes cell proliferation under glucose starvation through the miR-22/TCF7 axis.

Authors:  Chengguang Zhu; Xiangling He; Keke Chen; Zhijun Huang; Anqi Yao; Xin Tian; Yalan You; Minhui Zeng
Journal:  Cell Cycle       Date:  2021-03-02       Impact factor: 4.534

Review 10.  Molecular mechanisms and clinical applications of miR-22 in regulating malignant progression in human cancer (Review).

Authors:  Jingyu Wang; Yuan Li; Meiman Ding; Honghe Zhang; Xiaoming Xu; Jinlong Tang
Journal:  Int J Oncol       Date:  2016-12-19       Impact factor: 5.650

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.